By acting on this receptor, afamelanotide not only stimulates melanogenesis and promotes the transfer of eumelanin into melanosomes but because inflammatory cells, such as neutrophils or lymphocytes, can express the melanocortin 1 receptor (MC1R), it also acts on the altered inflammatory microenvironment of vitiligo lesions [105]. The gene discussed is MC1R; the disease is vitiligo.